Skip to content

Health and Sleep Assessment After the Strasbourg Attacks of December 11, 2018

Health and Sleep Assessment After the Strasbourg Attacks of December 11, 2018

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05620381
Acronym
ELSSAS
Enrollment
300
Registered
2022-11-17
Start date
2020-09-09
Completion date
2023-12-31
Last updated
2023-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Disorders, Post-Traumatic

Keywords

Stress Disorders, Disorders Post-Traumatic

Brief summary

Evaluation of the prevalence of post-traumatic stress disorder (PTSD), associated risk factors, health care consumption, and sleep disorders in a civilian population exposed to the December 11, 2018, attacks in Strasbourg. Terrorist attacks have unfortunately become all too frequent on our territory in recent years. A better knowledge of the psychological and psychiatric repercussions on exposed populations is essential in order to better prevent and treat disorders that can have a major functional impact on the lives of exposed individuals and to adapt care during future similar events

Interventions

None listed

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* Major subject (≥ 18 years old), * Having been exposed to the attacks of December 11, 2018 in Strasbourg directly or indirectly (presence at the scene or close relative present at the scene) * Subject who has not expressed his opposition, after information, to the reuse of his data for the purpose of this research

Exclusion criteria

* Subject who has expressed opposition to participating in the study * Subject under guardianship, curatorship or legal protection

Design outcomes

Primary

MeasureTime frame
Retrospective evaluation of the prevalence of post-traumatic stress disorder (PTSD) in a population exposed to the attacks of December 11, 2018 in StrasbourgFiles analysed retrospectively from February 11, 2018 to November 30, 2019 will be examined

Countries

France

Contacts

Primary ContactAmaury MENGIN, MD
amaury.mengin@chru-strasbourg.fr33 3 88 11 57 70

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026